These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Korean biotechs seize opportunity to list on public markets. Louët S Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042 [No Abstract] [Full Text] [Related]
7. Public markets show signs of life. Mitchell P Nat Biotechnol; 2003 Aug; 21(8):833-4. PubMed ID: 12894181 [No Abstract] [Full Text] [Related]
8. White biotechnology: ready to partner and invest in. Kircher M Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821 [TBL] [Abstract][Full Text] [Related]
10. Realizing potential: the state of Asian bioentrepreneurship. Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972 [No Abstract] [Full Text] [Related]
11. Overcoming the challenges in the pharma/biotech industry. Graul AI; Prous JR Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900 [TBL] [Abstract][Full Text] [Related]
12. Japanese giants renew interest in industrial biotech. Sipp D Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071 [No Abstract] [Full Text] [Related]